+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Traveler's Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Traveler's Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peptic Ulcer - Pipeline Insight, 2025 - Product Thumbnail Image

Peptic Ulcer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoglycemia- Pipeline Insight, 2025 - Product Thumbnail Image

Hypoglycemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ascites - Pipeline Insight, 2025 - Product Thumbnail Image

Ascites - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anal Fissure - Pipeline Insight, 2025 - Product Thumbnail Image

Anal Fissure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastric Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Ulcers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fecal Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Fecal Incontinence - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eosinophilic Esophagitis- Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Esophagitis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Duodenal Ulcer - Pipeline Insight, 2025 - Product Thumbnail Image

Duodenal Ulcer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Emesis- Pipeline Insight, 2025 - Product Thumbnail Image

Emesis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Dyspepsia- Pipeline Insight, 2025 - Product Thumbnail Image

Dyspepsia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aldose Reductase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Aldose Reductase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Constipation- Pipeline Insight, 2025 - Product Thumbnail Image

Constipation- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Irritable Bowel Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Irritable Bowel Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more